TLRY earnings: real EPS beat/miss history, analyst consensus Hold, P/E -0.22. Updated 2026-07-23.
Tilray Brands (TLRY) Research Hub
Tilray Brands (TLRY) trades on NASDAQ, CA in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 4.02 USD (-4.51%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.22, market cap 0.51B. This hub links to the full technical, earnings and options research available for TLRY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 4.02 USD (-4.51%) |
| 52-week range | 3.67 USD – 5.19 USD |
| Trend regime | Range |
| 14-day RSI | 35 (Bearish) |
| Trailing P/E | -0.22 |
| Market cap | 0.51B |
| Dividend yield | 0.00% |
Available research for TLRY
Covered Call on TLRY: how it works, illustrative setup around the real 4.02 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TLRY: how it works, illustrative setup around the real 4.02 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TLRY: how it works, illustrative setup around the real 4.02 USD price, max profit/loss, breakeven and when to use it. Educational.
TLRY technical analysis: range, last 4.02 USD, RSI 35, 52w range 3.67 USD–5.19 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TLRY in?
Tilray Brands (TLRY) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, CA.
Is TLRY in an uptrend or downtrend?
As of 2026-09-11, TLRY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TLRY's trailing P/E ratio?
TLRY's trailing P/E is -0.22, with a market cap of 0.51B. See the earnings research page for full valuation detail.